CytoCore, Inc. Appoints EVC Group as New Communications Counsel.CHICAGO -- CytoCore, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CYOE) announced today the appointment of EVC See VESA Enhanced Video Connector. Group, Inc. as its agency of record for investor relations Investor relations The process by which the corporation communicates with its investors. , corporate communications and trade media relations. The firm will create and implement a proactive program designed to build awareness among investors and other targeted audiences, and provide additional advisory services advisory services advisory services provided to the public, in their capacity as owners and managers of animals, are an important part of veterinary science. They may be provided by government bureaux, by commercial companies who deal in pharmaceuticals or animals or animal related to shareholder communications. "As CytoCore expands its European launch of the SoftPAP[TM] cell collector, and plans a U.S. launch within the next 90 days, it is important for our Company to continuously communicate our progress against plan as well as to expand our awareness with potential customers and investors," said Robert McCullough, Jr., CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "EVC Group is a business communications firm dedicated to serving small cap companies. Importantly, the firm has extensive experience in the healthcare field. In addition, EVC Group has a proven track record for generating new interest among actionable investors for their clients as well as impressive media relations capabilities. We look forward to working with the EVC team to increase public awareness and understanding of CytoCore." EVC Group, Inc. is headquartered in San Francisco and has offices in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The firm currently serves a select number of emerging growth companies in the health care, technology, consumer goods, mining, financial services and business services industries. About CytoCore Inc. CytoCore develops cost-effective cancer screening systems, which can be utilized in a laboratory or at the point-of-care, to assist in the early detection of cervical, endometrial endometrial /en·do·me·tri·al/ (en?do-me´tre-il) pertaining to the endometrium. endometrial, n relating to the end-ometrium or cavity of the uterus. , and other cancers. The CytoCore Solutions(tm) System is being developed to provide medical practitioners with highly accurate, low-cost, cervical and uterine cancer screening systems that can be seamlessly integrated into existing medical models. More information is available at: www.CytoCoreInc.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion